Also, the expression of CDX2 and SATB2 has been shown to be decreased in the epithelium of patients with inflammatory bowel disease, and Satb2-deficient mice are more prone to the development of colitis and colitis-associated cancer compared with control mice [23–25]. Here, SATB2 is linked to cancer.